CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)
[O2Micro Reports Third Quarter 2017 Financial Results Operational and Strategic Highlights: Q3 2017 results were within the range of guidance provided in August 2017. GAAP Net Loss per ADS in the third quarter of 2017 was 5 cents, with non-GAAP Net Loss of 4 cents per ADS. Revenue in the fourth quart]
OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports Third Quarter 2017 Financial Results Operational
[O2Micro Reports Third Quarter 2017 Financial Results Operational and Strategic Highlights: Q3 2017 results were within the range of guidance provided in August 2017. GAAP Net Loss per ADS in the third quarter of 2017 was 5 cents, with non-GAAP Net Loss of 4 cents per ADS. Revenue in the fourth quart]
GSH [GUANGSHEN RAILWAY CO] 6-K: (Original Filing)
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
GSH [GUANGSHEN RAILWAY CO] 6-K: (a joint stock limited company incorporated in the
[(a joint stock limited company incorporated in the Peoples Republic of China) (Stock Code: 00525) THIRD QUARTERLY REPORT FOR 2017 The financial information set out in this quarterly report has not been audited, and has been prepared in accordance with the PRC Enterprise Accounting Standards. 1. IMP]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Receipt of Delisting Determination Letter
[Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq BEIJING, November 3, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(”Sinovac”), a leading provider of biopharmaceutical products in China, announced today that on November 1, 2017, the Company received a delisti]
ATV [Acorn International] 6-K: (Original Filing)
[Acorn International Names Jacob A. Fisch CEO SHANGHAI, China, November 3, 2017 – Acorn International, Inc. (NYSE: ATV) (“Acorn” or the “Company”) today announced that its board of directors has appointed Jacob A. Fisch, current President, to the position of CEO and President of the Company, effectiv]
ATV [Acorn International] 6-K: Acorn International Names Jacob A. Fisch CEO SHANGHAI,
[Acorn International Names Jacob A. Fisch CEO SHANGHAI, China, November 3, 2017 – Acorn International, Inc. (NYSE: ATV) (“Acorn” or the “Company”) today announced that its board of directors has appointed Jacob A. Fisch, current President, to the position of CEO and President of the Company, effectiv]
